Rheumatology · Jackson, TN
NPI
1679610745
Since 2007
Specialty
Rheumatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
371 N Parkway Ste 400
Jackson, TN, 38305
Phone (731) 664-0002
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
207,175 services
Medicare patients, 2024
745
Average age 74
Drug cost, 2024
$1.4M
2,946 prescriptions
Company payments, 2025
$55K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Satish K Odhav was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 116,800 times for 48 patients. In total Satish K Odhav billed 207,175 services in 82 codes, and Medicare paid $1.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 116,800 | 48 | $3.63 | $424K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 54,390 | 62 | $8.61 | $468K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 12,250 | 17 | $8.97 | $110K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,941 | 12 | $0.23 | $441 |
| 36415 Venipuncture Blood Collection | Office | 1,802 | 699 | $8.58 | $15K |
| 85025 Blood Count | Office | 1,735 | 665 | $7.51 | $13K |
| 80053 Clinical Chemistry | Office | 1,729 | 668 | $10.20 | $18K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,560 | 26 | $0.10 | $159 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,419 | 613 | $11.52 | $16K |
| 99214 Office E&M - Established | Office | 1,414 | 603 | $84.19 | $119K |
| 86140 Clinical Chemistry | Office | 1,238 | 443 | $5.02 | $6,220 |
| 96401 Chemotherapy Administration | Office | 588 | 50 | $50.24 | $30K |
| 96372 Injection Administration | Office | 525 | 69 | $10.41 | $5,467 |
| 99213 Office E&M - Established | Office | 425 | 206 | $60.78 | $26K |
| 73620 X-ray - Lower Extremity | Office | 415 | 208 | $19.34 | $8,024 |
By year: 2022 $1.1M for 155,332 services; 2023 $1.2M for 163,559 services; 2024 $1.9M for 207,175 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,802 | 699 | $8.58 | $15K |
| 85025 Blood Count | 1,735 | 665 | $7.51 | $13K |
| 80053 Clinical Chemistry | 1,729 | 668 | $10.20 | $18K |
| 86140 Clinical Chemistry | 1,238 | 443 | $5.02 | $6,220 |
| 85652 Clinical Chemistry | 346 | 200 | $2.63 | $909 |
| 81002 Clinical Chemistry | 93 | 49 | $3.38 | $314 |
| 84550 Clinical Chemistry | 76 | 35 | $4.40 | $335 |
| 82550 Clinical Chemistry | 75 | 58 | $6.29 | $472 |
| 86160 Immunoassay | 68 | 34 | $11.41 | $776 |
| 86431 Immunoassay | 57 | 57 | $5.56 | $317 |
Medicare prescription drug claims, 2024
In 2024, the drug Satish K Odhav prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 850 prescriptions and refills. In total Satish K Odhav wrote 2,946 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 850 | 1,505 | 177 | $20K |
| Hydroxychloroquine Sulfate Generic | 586 | 983 | 145 | $22K |
| Prednisone Generic | 426 | 522 | 131 | $1,709 |
| Folic Acid Generic | 160 | 317 | 37 | $505 |
| Allopurinol Generic | 84 | 155 | 21 | $599 |
| Tramadol Hcl Generic | 79 | 79 | 19 | $313 |
| Azathioprine Generic | 62 | 92 | 13 | $1,405 |
| Rinvoq Upadacitinib | 60 | 60 | Under 11 | $375K |
| Meloxicam Generic | 56 | 132 | 21 | $224 |
| Celecoxib Generic | 43 | 61 | 11 | $650 |
| Olumiant Baricitinib | 42 | 50 | Under 11 | $130K |
| Sulfasalazine Generic | 40 | 66 | 13 | $727 |
| Zolpidem Tartrate Generic | 37 | 37 | Under 11 | $133 |
| Omeprazole Generic | 36 | 68 | Under 11 | $428 |
| Xeljanz Tofacitinib Citrate | 31 | 31 | Under 11 | $179K |
Brand drugs: - claims; generic drugs: 2,671 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Satish K Odhav $55K ($55K in general payments such as food, travel and fees) from 14 companies. The largest payer was UCB, Inc. with $35K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 58 | $35K |
| Abbvie Inc. ABBV | 79 | $16K |
| Janssen Biotech, Inc. JNJ | 12 | $2,577 |
| Pfizer Inc. PFE | 21 | $397 |
| Amgen Inc. AMGN | 23 | $348 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $215 |
| Mallinckrodt Hospital Products Inc. | 4 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $158 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $147 |
| GlaxoSmithKline, LLC. GSK | 6 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.